Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Shouyao Holdings (Beijing) Co. Ltd. A (688197) operate in?
Shouyao Holdings (Beijing) Co. Ltd. A belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Shouyao Holdings (Beijing) Co. Ltd. A (688197) current stock price?
As of the latest data, Shouyao Holdings (Beijing) Co. Ltd. A stock price is CN¥37.72, with a previous close of CN¥39.46. Shouyao Holdings (Beijing) Co. Ltd. A lost -CN¥1.74 in the last trading session, representing a -4.41% loss.
What is Shouyao Holdings (Beijing) Co. Ltd. A (688197) current market capitalization?
Shouyao Holdings (Beijing) Co. Ltd. A market cap is approximately 5.61 billion.
What is Shouyao Holdings (Beijing) Co. Ltd. A (688197) Earnings Per Share (EPS)?
The trailing EPS is -CN¥0.58.
Does Shouyao Holdings (Beijing) Co. Ltd. A (688197) pay dividends?
No. Shouyao Holdings (Beijing) Co. Ltd. A does not pay a dividend.
What is Shouyao Holdings (Beijing) Co. Ltd. A (688197) beta (volatility) score?
Shouyao Holdings (Beijing) Co. Ltd. A has a beta of 0.669, indicating lower volatility than the overall market.